LI ZHAO
Quick facts
Marketed products
- rhBNP · Cardiovascular
rhBNP (recombinant human B-type natriuretic peptide) mimics the body's natural natriuretic peptide to promote vasodilation, reduce cardiac preload and afterload, and improve hemodynamics in acute decompensated heart failure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about LI ZHAO
What are LI ZHAO's marketed drugs?
Top marketed products include rhBNP.
Related
- rhBNP · Cardiovascular
- Sector hub: All tracked pharma companies